Free Trial
NASDAQ:MASS

908 Devices Q3 2026 Earnings Date & Estimates

908 Devices logo
$10.78 +0.58 (+5.63%)
As of 01:34 PM Eastern
This is a fair market value price provided by Massive. Learn more.

908 Devices is scheduled to report Q3 2026 earnings on Tuesday, November 10, 2026, before market opens. The conference call is scheduled for 8:30 AM ET.

Upcoming Earnings Announcement

Quarter
Q3 2026
Announcement Date
Time
Before Market Opens
Conference Call
8:30 AM ET

What Analysts Expect from 908 Devices in Q3 2026

908 Devices is expected to post earnings of -$0.16 per share on revenue of $18.31 million. In the same quarter a year earlier 908 Devices reported -$0.15 per share on revenue of $14.01 million. 908 Devices last reported on August 11, 2026, posting -$0.11 per share and beating the -$0.1420 consensus estimate. 908 Devices has beaten the consensus EPS estimate in 6 of its last 8 quarters.

Consensus Estimates

Consensus EPS
-$0.16
Expected Revenue
$18.31 million
Prior-Year EPS
-$0.15
Prior-Year Revenue
$14.01 million
Expected Revenue Growth
+30.7%

Recent Track Record

Last Reported
Q2 2026
Last Quarter EPS
-$0.11 (Beat by +$0.0320)
Last Quarter Revenue
$16.07 million
EPS Beat Rate
6 of last 8 quarters

908 Devices Q3 2026 Earnings FAQ

908 Devices (NASDAQ:MASS) has confirmed it will report Q3 2026 earnings on Tuesday, November 10, 2026, before market opens.

908 Devices' Q3 2026 earnings conference call is scheduled for Tuesday, November 10, 2026 at 8:30 AM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date.

Analysts expect 908 Devices to post earnings of -$0.16 per share for Q3 2026.

The consensus revenue estimate for 908 Devices is $18.31 million for Q3 2026.

908 Devices Earnings Headlines

Bank of America: 'Digital Dollar Inevitable'
Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the digital dollar. They gave us the timeline… 2025 to 2030. We're in that window right now. Once the digital dollar launches, every transaction you make will be tracked. Your spending could be controlled. Your accounts could be frozen. Over 4,500 investors have already used this legal backdoor to hold assets CBDCs can't freeze and generate yields the Federal Reserve can't touch.tc pixel
Roth MKM Keeps Their Buy Rating on 908 Devices (MASS)
See More 908 Devices Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like 908 Devices? Sign up for Earnings360's daily newsletter to receive timely earnings updates on 908 Devices and other key companies, straight to your email.

About 908 Devices

908 Devices (NASDAQ:MASS) is a Boston-based analytical technology company that develops purpose-built mass spectrometers for use outside traditional laboratory environments. Its instruments are designed to provide rapid chemical and biological analysis in the field, helping users identify unknown substances and make time-sensitive decisions.

The company’s product portfolio includes the MX908 handheld mass spectrometer, which is used to detect and identify chemical threats, explosives, narcotics and other hazardous materials. 908 Devices also offers instruments and systems for applications in public safety, defense, industrial operations, life sciences and pharmaceutical research, including solutions intended for process monitoring and laboratory workflows.

Founded in 2012, 908 Devices was established to commercialize compact mass-spectrometry technology and has expanded its offerings for government, commercial and research customers. Its products are marketed in the United States and internationally. Kevin Knopp, a company co-founder, serves as president and chief executive officer.

View 908 Devices Profile